{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:12:22Z","timestamp":1775707942834,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/ftd.0000000000000056","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T12:37:53Z","timestamp":1404477473000},"page":"584-589","source":"Crossref","is-referenced-by-count":27,"title":["Predictive Performance of a Gentamicin Population Pharmacokinetic Model in Neonates Receiving Full-Body Hypothermia"],"prefix":"10.1097","volume":"36","author":[{"given":"Mario R.","family":"Sampson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Frymoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Rattray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"Cotten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Capparelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia L.","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cohen-Wolkowiez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-3782(85)90082-9","article-title":"Maturation of glomerular filtration in preterm and mature babies.","volume":"11","author":"Coulthard","year":"1985","journal-title":"Early Hum Dev"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-1033.1997.00625.x","article-title":". Expression of CYP3A in the human liverevidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.","volume":"247","author":"Lacroix","year":"1997","journal-title":"Eur J Biochem"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1542\/peds.98.1.143","article-title":"Unapproved uses of approved drugs: the physician, the package insert, and the food and drug administration: subject review. American academy of pediatrics committee on drugs.","volume":"98","year":"1996","journal-title":"Pediatrics"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1185\/146300907X167781","article-title":"Problems and pitfalls performing pharmacokinetic studies in children.","volume":"8","author":"Anderson","year":"2007","journal-title":"Paediatr Perinat Drug Ther"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1185\/1463009001505286","article-title":". Recruiting children to a clinical trial.","volume":"4","author":"Peden","year":"2000","journal-title":"Paediatr Perinat Drug Ther"},{"key":"R7-5-20210129","first-page":"203","article-title":". Analgesic trials in neonates: observations, pitfalls and recommendations.","volume":"6","author":"van Dijk","year":"2005","journal-title":"Paediatr Perinat Drug Ther"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/phar.1263","article-title":". Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.","volume":"33","author":"Frymoyer","year":"2013","journal-title":"Pharmacotherapy"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00228-012-1413-4","article-title":". Population pharmacokinetics of piperacillintazobactam in neonates and young infants.","volume":"69","author":"Li","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2125.2012.04392.x","article-title":". Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.","volume":"75","author":"Patel","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jp.2010.146","article-title":"Physiologic and pharmacologic considerations for hypothermia therapy in neonates.","volume":"31","author":"Zanelli","year":"2011","journal-title":"J Perinatol"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/jp.2013.59","article-title":". Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.","volume":"33","author":"Frymoyer","year":"2013","journal-title":"J Perinatol"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMcps050929","article-title":". Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.","volume":"353","author":"Shankaran","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","article-title":"Development and evaluation of a generic physiologically based pharmacokinetic model for children.","volume":"45","author":"Edginton","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40262-013-0096-z","article-title":"Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.","volume":"53","author":"Vogt","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10928-009-9143-7","article-title":". Evaluation of different tests based on observations for external model evaluation of population analyses.","volume":"37","author":"Brendel","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11536750-000000000-00000","article-title":". Predictive performance of a recently developed population pharmacokinetic model for morphine and its metabolites in new datasets of (preterm) neonates, infants and children.","volume":"50","author":"Krekels","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1542\/peds.104.6.e76","article-title":". Plasma creatinine rises dramatically in the first 48 hours of life in preterm infants.","volume":"104","author":"Miall","year":"1999","journal-title":"Pediatrics"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/clinchem\/43.1.205","article-title":"Assessing fluid and electrolyte status in the newborn. National Academy of Clinical Biochemistry.","volume":"43","author":"Lorenz","year":"1997","journal-title":"Clin Chem"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00003088-200746030-00003","article-title":". Are population pharmacokinetic andor pharmacodynamic models adequately evaluated A survey of the literature from 2002 to 2004.","volume":"46","author":"Brendel","year":"2007","journal-title":"Clin Pharmacokinet"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T13:36:59Z","timestamp":1649597819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201410000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000056","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}